These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27385525)

  • 21. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
    Powers R; Gordon R; Roberts K; Kovach R
    Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A man with blisters on hand and feet].
    Gelderblom AJ; van der Rhee JI; Ouwerkerk J
    Ned Tijdschr Geneeskd; 2011; 155(45):A3994. PubMed ID: 22085574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract]   [Full Text] [Related]  

  • 24. Violaceous plaques in a patient with acquired immunodeficiency syndrome.
    Bessinger GT; Conologue TD; Krivda SJ; Turiansky GW
    Arch Dermatol; 2003 Feb; 139(2):215-20. PubMed ID: 12588229
    [No Abstract]   [Full Text] [Related]  

  • 25. Disseminated superficial actinic porokeratosis like drug eruption: a case report.
    Hwang SM; Choi EH; Ahn SK
    J Korean Med Sci; 1999 Apr; 14(2):227-9. PubMed ID: 10331575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recurrent purpuric lesion on back of hand].
    Santiago Sánchez-Mateos JL; Aboín González S; Beà Ardébol S; Carrillo Gijón R; Muñoz Zato E; Jaén Olasolo P
    Rev Clin Esp; 2009 Jan; 209(1):43-5. PubMed ID: 19268096
    [No Abstract]   [Full Text] [Related]  

  • 27. Interstitial granulomatous drug reaction to sorafenib.
    Martínez-Morán C; Nájera L; Ruiz-Casado AI; Romero-Maté A; Espinosa P; Meseguer-Yebra C; Córdoba S; Borbujo JM
    Arch Dermatol; 2011 Sep; 147(9):1118-9. PubMed ID: 21931061
    [No Abstract]   [Full Text] [Related]  

  • 28. Fixed drug eruption to tartrazine.
    Orchard DC; Varigos GA
    Australas J Dermatol; 1997 Nov; 38(4):212-4. PubMed ID: 9431719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcerative lichen planus-like dermatitis associated with hydroxyurea.
    Renfro L; Kamino H; Raphael B; Moy J; Sanchez M
    J Am Acad Dermatol; 1991 Jan; 24(1):143-5. PubMed ID: 1825667
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixed drug eruption due to naproxen; lack of cross-reactivity with other propionic acid derivatives.
    Gonzalo MA; Alvarado MI; Fernández L; Rosendo R; González G
    Br J Dermatol; 2001 Jun; 144(6):1291-2. PubMed ID: 11422076
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluconazole-induced fixed drug eruption confirmed by extemporaneous patch testing.
    Khan M; Paul N; Fernandez C; Wakelin S
    Contact Dermatitis; 2020 Dec; 83(6):507-508. PubMed ID: 32542690
    [No Abstract]   [Full Text] [Related]  

  • 32. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 33. Fixed drug eruption due to cimetidine.
    Inoue A; Teramae H; Hisa T; Taniguchi S; Chanoki M; Hamada T
    Acta Derm Venereol; 1995 May; 75(3):250. PubMed ID: 7653194
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic penile ulceration in a 72-year-old man.
    Geraminejad PA; Walling HW; Swick BL; Sontheimer RD
    Arch Dermatol; 2004 Jul; 140(7):877-82. PubMed ID: 15262703
    [No Abstract]   [Full Text] [Related]  

  • 35. Dose-dependent, non-pigmenting fixed drug eruption with eczematous lesions induced by bosutinib: case report.
    Youh J; Yamaguchi Y; Kawamura T; Hoshina D
    Pan Afr Med J; 2023; 46():95. PubMed ID: 38405098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A haemorrhagic bullous eruption of the hands caused by phenylbutazone: a report of 3 cases.
    Millard LG
    Acta Derm Venereol; 1977; 57(1):83-6. PubMed ID: 74176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eruptive keratoacanthomas secondary to nivolumab immunotherapy.
    Bednarek R; Marks K; Lin G
    Int J Dermatol; 2018 Mar; 57(3):e28-e29. PubMed ID: 29318617
    [No Abstract]   [Full Text] [Related]  

  • 38. Pseudoephedrine may cause "pigmenting" fixed drug eruption.
    Ozkaya E; Elinç-Aslan MS
    Dermatitis; 2011 May; 22(3):E7-9. PubMed ID: 21569741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aquagenic syringeal acrokeratoderma.
    Darlenski R; Tsankov N
    J Dtsch Dermatol Ges; 2012 Mar; 10(3):198. PubMed ID: 22128881
    [No Abstract]   [Full Text] [Related]  

  • 40. An allergic eruption probably caused by ketoconazole.
    van Ketel WG
    Contact Dermatitis; 1983 Jul; 9(4):313-3. PubMed ID: 6311485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.